<DOC>
	<DOCNO>NCT00419835</DOCNO>
	<brief_summary>Chronic kidney disease ( CKD ) become significant health problem worldwide . Strategies decrease rate progression disease reduce number patient need dialysis renal transplantation urgently need . In study wish compare effect dual blockade renin-angiotensin system ( ACE inhibitor plus angiotensin II receptor blocker ) compare effect ACE inhibitor monotherapy patient diabetic chronic nephropathy .</brief_summary>
	<brief_title>Effect Enalapril Losartan Association Therapy Proteinuria Inflammatory Biomarkers Diabetic Nephropathy : Clinical Trial Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>Diabetic kidney disease current lead cause chronic kidney disease ( CKD ) world . Despite effort control disease , rate CKD progression still high significant number patient ultimately need renal replacement therapy . Pharmacological blockade renin-angiotensin system one key element CKD secondary prevention , ACE inhibitor angiotensin II receptor 1 blocker ( ARB ) use purpose . However , still clear dual blockade ( ACEi ARBs simultaneously ) superior monotherapy ACE inhibitor ARBs . A recent trial suggest dual blockade superior monotherapy non-diabetic chronic kidney disease . The purpose trial evaluate effect combination therapy compare ACE inhibitor alone type 2 diabetic patient macroalbuminuric diabetic nephropathy .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Enalaprilat</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>diabetic nephropathy characterise daily proteinuria superior 500 mg type II diabetes type 1 diabetes serum creatinine &gt; 2.5 mg/dL creatinine clearance low 30 ml/min serum potassium &gt; 5.5 mEq/L intolerance allergy ACE inhibitor BRA pregnancy hepatitis C B HIV current chemotherapy treatment</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>diabetic nephropathy</keyword>
	<keyword>proteinuria</keyword>
	<keyword>CKD progression</keyword>
	<keyword>dialysis</keyword>
</DOC>